Page last updated: 2024-12-04

bendiocarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bendiocarb: FICAM 80W contains 80% of the above chemical cpd as the active ingredient [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2314
CHEMBL ID465018
CHEBI ID34556
SCHEMBL ID22080
MeSH IDM0051076

Synonyms (117)

Synonym
1,3-benzodioxol-4-ol, 2,2-dimethyl-, methylcarbamate
bendiocarb
DIVK1C_006644
KBIO1_001588
seedox 80w
methylcarbamic acid 2,3-(isopropylidenedioxy)phenyl ester
2,2-dimethylbenzo-1,3-dioxol-4-yl methylcarbamate
2,2-dimethyl-1,3-benzodioxole-n-methylcarbamate
fisons nc 6897
tatoo
oms-1394
bencarbate
tattoo
ficam 80w
einecs 245-216-8
bendiocarb [ansi:bsi:iso]
2,3-isopropylidene-dioxyphenyl methylcarbamate
turcam
1,3-benzodioxol-4-ol, 2,2-dimethyl-, methyl carbamate
epa pesticide chemical code 105201
carbamic acid, methyl-, 2,3-(isopropylidenedioxy)phenyl ester
carbamic acid, methyl-, 2,3-(dimethylmethylenedioxy)phenyl ester
brn 1315404
ccris 9062
ficam z
rotate
hsdb 3918
ficam ulv' ul
garvox
rcra waste no. u278
bendiocarbamate
ai3-27695
dycarb
ficam d
nc6897
2,2-dimethyl-1,3-benzdioxol-4-yl n-methylcarbamate
bendiocarbe [iso-french]
1,3-benzodioxole, 2,2-dimethyl-4-(n-methylaminocarboxylato)-
1,3-benzodioxole, 2,2-dimethyl-4-(n-methylcarbamato)-
ficam ulv
ficam w
ficam b
multimet
ficam
multamat
niomil
CHEBI:34556 ,
2,3-isopropylidenedioxyphenyl methylcarbamate
22781-23-3
2,2-dimethyl-1,3-benzodioxol-4-yl methylcarbamate
2,2-dimethyl-1,3-benzodioxol-4-ol methylcarbamate
2,2-dimethyl-4-(methylcarbamoyloxy)-1,3-benzodioxole
SPECTRUM_001917
SPECTRUM5_002026
BSPBIO_002467
NCGC00094543-03
NCGC00094543-02
NCGC00094543-01
KBIO3_001967
KBIOGR_001187
KBIO2_007588
KBIOSS_002459
KBIO2_005020
KBIO2_002452
SPECTRUM2_001726
SPECPLUS_000548
SPECTRUM4_000694
SPECTRUM3_000854
SPBIO_001772
SPECTRUM330063
NCGC00094543-05
NCGC00094543-04
MLS002695990
smr000777869
CHEMBL465018
inchi=1/c11h13no4/c1-11(2)15-8-6-4-5-7(9(8)16-11)14-10(13)12-3/h4-6h,1-3h3,(h,12,13)
xeggryvflwgfhi-uhfffaoysa-
(2,2-dimethyl-1,3-benzodioxol-4-yl) n-methylcarbamate
NCGC00094543-07
NCGC00094543-06
HMS3087C14
NCGC00259111-01
NCGC00254681-01
tox21_201562
dtxsid9032327 ,
tox21_300777
cas-22781-23-3
dtxcid7012327
CCG-39499
unii-qfh0zu0a5u
bendiocarbe
qfh0zu0a5u ,
nc 6897
2,2-dimethyl-1,3-benzodioxol-4-yl n-methylcarbamate
1,3-benzodioxol-4-ol,2,2-dimethyl-, 4-(n-methylcarbamate)
AKOS015888418
bendiocarb [mart.]
bendiocarb [iso]
bendiocarb [mi]
bendiocarb [hsdb]
SCHEMBL22080
ficam plus (salt/mix)
garvox 3g
sedox
ficam 80 w
seedoxin
2,2-dimethyl-1,3-benzodioxol-4-yl methylcarbamate #
fuam
bdbm50064618
bendiocarb, pestanal(r), analytical standard
J-014852
2,2-dimethylbenzo[d][1,3]dioxol-4-yl methylcarbamate
Q417017
F21336
6,8-dichloro-3-ethyl-2h-benzo[e][1,2,4]thiadiazine 1,1-dioxide
carbamic acid, n-methyl-, 2,3-isopyridenyldioxyphenyl ester
2,2-dimethyl-2h-1,3-benzodioxol-4-yl n-methylcarbamate

Research Excerpts

Overview

Bendiocarb is a broad-spectrum insecticide used to control disease vectors such as mosquitoes and flies. It is used more in indoor areas, especially against scorpions, spiders, flies, mosquitoes and cockroaches.

ExcerptReferenceRelevance
"Bendiocarb is a carbamate insecticide, which is used more in indoor areas, especially against scorpions, spiders, flies, mosquitoes and cockroaches. "( Investigation of the efficacy of diosmin against organ damage caused by bendiocarb in male Wistar albino rats.
Bahar, O; Eraslan, G, 2023
)
2.59
"Bendiocarb is a pesticide carbamate which is used to protect agricultural products and animals. "( Bendiocarb-induced nephrotoxicity in rats and the protective role of vitamins C and E.
Adiguzel, C; Kalender, Y, 2020
)
3.44
"Bendiocarb is a carbamate broad-spectrum insecticide used to control disease vectors such as mosquitoes and flies, as well as household and agricultural pests. "( Effect of N-metylcarbamate pesticide bendiocarb on cattle lymphocytes after in vitro exposure.
Dianovský, J; Holecková, B; Siviková, K, 2009
)
2.07
"Bendiocarb was found to be a good alternative insecticide for IRS in Benin, in areas where An."( Dramatic decrease in malaria transmission after large-scale indoor residual spraying with bendiocarb in Benin, an area of high resistance of Anopheles gambiae to pyrethroids.
Akogbeto, M; Bankole, HS; Gazard, DK; Gbedjissi, GL; Padonou, GG, 2011
)
1.31

Treatment

ExcerptReferenceRelevance
"Bendiocarb treatment decreased the antioxidant enzyme activities, FRAP and TEAC values and increased malondialdehyde levels compared to control."( Bendiocarb induced histopathological and biochemical alterations in rat liver and preventive role of vitamins C and E.
Apaydin, FG; Baş, H; Kalender, S; Kalender, Y, 2017
)
2.62

Toxicity

ExcerptReferenceRelevance
" The importance of effective training, adequate protective clothing and good personal hygiene in achieving safe application of insecticides in house-spraying programmes is stressed."( The safety evaluation of bendiocarb, a residual insecticide for vector control.
Bonsall, JL; Goose, J, 1986
)
0.57
" The alterations in the activities of the antioxidant defence system, increased TBARS values, and changes in the SOD isoenzyme pattern showed that the toxic effect of bendiocarb is not only in the acetylcholine esterase inhibition, but also in ROS production."( The another toxic effect of carbamate insecticides.
Flesárová, S; Holovská, K; Javorský, P; Lenártová, V; Sobeková, A, 2009
)
0.55
"In the President's Malaria Initiative (PMI)-funded Africa Indoor Residual Spraying Project (AIRS), end-of-day clean-up operations require the safe disposal of wash water resulting from washing the exterior of spray tanks and spray operators' personal protective equipment."( Mobile soak pits improve spray team mobility, productivity and safety of PMI malaria control programs.
Belemvire, A; Bouare, SI; Brown, AS; Chandonait, PJ; Fornadel, C; George, K; Longhany, R; Mitchell, DF; Norris, L, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
" Policy makers should consider deploying IRS in combination with ITNs to control transmission if local ITN strategies on their own are insufficiently effective."( Indoor residual spraying in combination with insecticide-treated nets compared to insecticide-treated nets alone for protection against malaria: a cluster randomised trial in Tanzania.
Kisinza, W; Kivaju, Z; Kleinschmidt, I; Mosha, FW; Protopopoff, N; Rowland, M; Tigererwa, R; West, PA; Wright, A, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
" In particular, excipient nanoemulsions can enhance the bioavailability of nutraceuticals in fruit- and vegetable-containing products consumed with them."( Impact of Pesticide Type and Emulsion Fat Content on the Bioaccessibility of Pesticides in Natural Products.
Li, R; Lv, S; McClements, DJ; Tan, Y; Zhang, R; Zhang, Z, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
"8%) had a significantly higher proportion of households that met the expected target dosage (100-400 mg/m(2)) compared to Karagwe (68."( Use of insecticide quantification kits to investigate the quality of spraying and decay rate of bendiocarb on different wall surfaces in Kagera region, Tanzania.
Emmanuel, I; Kafuko, JM; Lalji, S; Magesa, SM; Molteni, F; Morou, E; Mugalura, FE; Mutagahywa, J; Mwalimu, CD; Ndong, I; Ngondi, JM; Protopopoff, N; Ramsan, MM; Reithinger, R; Rowland, M; Thawer, NG; Vontas, J; Willilo, R; Wright, A, 2015
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
carbamate insecticideDerivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency2.48910.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency10.00000.000221.22318,912.5098AID588515
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency48.96620.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency17.86160.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency18.01780.000817.505159.3239AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency70.79460.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency34.25280.000229.305416,493.5996AID743069; AID743078; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency23.61210.001024.504861.6448AID743212; AID743215
Histone H2A.xCricetulus griseus (Chinese hamster)Potency117.51150.039147.5451146.8240AID1224845; AID1224896
heat shock protein beta-1Homo sapiens (human)Potency54.94100.042027.378961.6448AID743210
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency33.58750.168316.404067.0158AID720504
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency22.63470.000627.21521,122.0200AID651741; AID743202; AID743219
DNA dC->dU-editing enzyme APOBEC-3F isoform aHomo sapiens (human)Potency3.16230.025911.239831.6228AID602313
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (36)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID379115Insecticidal activity against insecticide-resistant Blattella germanica Muncie second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID671039Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID671042Toxicity in Anopheles gambiae G3 assessed as mortality treated as tarsal contact using dried filter papers after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1192964Selectivity ratio of Ki for recombinant wild-type Anopheles gambiae AChE to Ki for recombinant Anopheles gambiae AChE G119S mutant2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID379114Insecticidal activity against insecticide-susceptible Blattella germanica Jwax second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1192961Inhibition of recombinant wild-type Anopheles gambiae AChE compound incubated for up to 6 min at approximately 1 min interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192960Resistant ratio of LC50 for Anopheles gambiae Akron (MRA-913) to LC50 for Anopheles gambiae G3 (MRA-112)2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID379118Ratio of LT50 for Blattella germanica Muncie second instars to LT50 for Blattella germanica Jwax second instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID379119Ratio of LT50 for Blattella germanica Muncie fifth instars to LT50 for Blattella germanica Jwax fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID1192963Inhibition of recombinant human AChE2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID379117Insecticidal activity against insecticide-resistant Blattella germanica Muncie fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID671043Toxicity in anesthetized Anopheles gambiae G3 assessed as mortality treated as topical application assessed per mosquito after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1192955Tarsal contact toxicity in Anopheles gambiae G3 (MRA-112) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1422750Insecticidal activity against topically dosed female adult Aedes aegypti assessed as mortality measured after 24 hrs2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency.
AID671041Selectivity ratio of Ki for Anopheles gambiae AChE to Ki for human recombinant AChE2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID379116Insecticidal activity against insecticide-susceptible Blattella germanica Jwax fifth instars1999Journal of natural products, Mar, Volume: 62, Issue:3
Annonaceous acetogenins: recent progress.
AID671040Inhibition of human recombinant AChE after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1192957Tarsal contact toxicity in Anopheles gambiae Akron (MRA-913) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID1192962Inhibition of recombinant Anopheles gambiae AChE G119S mutant compound incubated for up to 60 mins at approximately 10 mins interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID671037Inhibition of Anopheles gambiae AChE2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (174)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (10.92)18.7374
1990's21 (12.07)18.2507
2000's17 (9.77)29.6817
2010's87 (50.00)24.3611
2020's30 (17.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.03 (24.57)
Research Supply Index5.25 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index68.22 (26.88)
Search Engine Supply Index3.96 (0.95)

This Compound (28.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (2.72%)5.53%
Reviews3 (1.63%)6.00%
Case Studies3 (1.63%)4.05%
Observational1 (0.54%)0.25%
Other172 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]